Cargando…
Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?
[Image: see text] The ATP site of kinases displays remarkable conformational flexibility when accommodating chemically diverse small molecule inhibitors. The so-called activation segment, whose conformation controls catalytic activity and access to the substrate binding pocket, can undergo a large c...
Autores principales: | Zhao, Zheng, Wu, Hong, Wang, Li, Liu, Yi, Knapp, Stefan, Liu, Qingsong, Gray, Nathanael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068218/ https://www.ncbi.nlm.nih.gov/pubmed/24730530 http://dx.doi.org/10.1021/cb500129t |
Ejemplares similares
-
Systematic Exploration of Privileged Warheads for Covalent Kinase Drug Discovery
por: Zhao, Zheng, et al.
Publicado: (2022) -
s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation
por: Sharma, Anamika, et al.
Publicado: (2021) -
Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode
por: Hu, Chen, et al.
Publicado: (2017) -
Correction to Discovery of a Potent and Selective
DDR1 Receptor Tyrosine Kinase Inhibitor
por: Kim, Hyung-Gu, et al.
Publicado: (2014) -
Discovery of a Potent and Selective DDR1 Receptor
Tyrosine Kinase Inhibitor
por: Kim, Hyung-Gu, et al.
Publicado: (2013)